Abstract
Background Multiple reports have pointed towards involvement of community and socioeconomic characteristics of people in the United States may be associated with COVID-19 cases and deaths.
Methods In this study, zip-code level data from 5 major metropolitan areas, was utilized to study the effect of multiple demographic & socioeconomic factors – including race, age, income, chronic disease comorbidity, population density, number of people per household on number of positive cases and ensuing death. Adjusted linear regression analysis using 13 to 16 such variables was performed.
Results Overall, 442 zip codes reporting 93,170 positive COVID-19 cases and 138 zip codes reporting mortality ranging from 0 to 25 were included in this study. A multivariable linear regression model noted that 1% increase in the proportion of residents above the age of 65 years, proportion of African American residents, proportion of females, persons per household and population density of the zip code increased the proportion of positive cases by 0.77%, 0.23%, 1.64%, 1.83% and 0.46% respectively (P<0.01) with only population density remaining significant in zip codes with greater than median number of cases. In zips with greater than median number of deaths, no community/socio-economic factor contributed significantly to death.
Conclusion This study gives early signals of gender, and racial inequalities while providing overwhelming evidence of how population density may contribute to an increase in the number of positive cases of COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by NIH grant P30 CA016058, and K12-CA133250 (DA) grants.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
All authors have read and approved this manuscript.
Concept and design: AG, and DA.
Acquisition, analysis, or interpretation of data: AG, JB, and AD.
Drafting of the manuscript: AG, JB and DA.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: AG.
Administrative, technical, or material support: AG, and DA.
Supervision: DA.
Funding: This work was supported in part by NIH grant P30 CA016058, and K12-CA133250 (DA) grants.
Disclosures: All authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Data Availability
This study was performed using publicly available data and complies with the Declaration of Helsinki, however given the public nature of the data locally appointed ethics committee approval and informed consent was not required.
